Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eiken Chemical CoTSE:4549 +0.47%79 EV-to-EBIT is 15.62 as of Aug. 27, 2026, which is 12% above its 10-year median of 14.00. GuruFocus rates TSE:4549 with a GF Score™ of 79/100 and a GF Value™ of 円2,494.45 (Fairly Valued). The stock has 4 warning signs investors should review. Among 481 Medical Devices & Instruments companies, Eiken Chemical Co ranks better than 59.88% on this metric.
The historical rank and industry rank for Eiken Chemical Co's EV-to-EBIT or its related term are showing as below:
TSE:4549'
s EV-to-EBIT Range Over the Past 10 Years
Min: 4.62 Med: 14 Max: 26
Current: 15.62
During the past 13 years, the highest EV-to-EBIT of Eiken Chemical Co was 26.00. The lowest was 4.62. And the median was 14.00.
TSE:4549's EV-to-EBIT is ranked better than 59.88% of 481
companies
in the Medical Devices & Instruments industry
Industry Median: 18.88
vs TSE:4549: 15.62
Eiken Chemical Co (TSE:4549) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Eiken Chemical Co's Enterprise Value for the quarter that ended in Mar. 2026 was 円96,705 Mil.
Eiken Chemical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,704 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eiken Chemical Co EV-to-EBIT Related Terms
Eiken Chemical Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Eiken Chemical Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Eiken Chemical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eiken Chemical Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eiken Chemical Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Eiken Chemical Co's EV-to-EBIT falls into.
Eiken Chemical Co's current Enterprise Value is 円73,456 Mil.
Eiken Chemical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,704 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eiken Chemical Co (TSE:4549) has a EV-to-EBIT of 15.62 as of Aug. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Eiken Chemical Co and its competitors. This is 12% above median its historical median of 14.00. Over the past decade, Eiken Chemical Co's EV-to-EBIT has ranged from 4.62 to 26.00. According to the industry distribution chart, Eiken Chemical Co ranks #193 out of 481 companies in the Medical Devices & Instruments industry, placing it in the top 40.1%.
Is Eiken Chemical Co's EV-to-EBIT too high?
Eiken Chemical Co's current EV-to-EBIT of 15.62 is 12% above median its 10-year median of 14.00. Over the past 10 years, this metric has ranged from a low of 4.62 to a high of 26.00. The Medical Devices & Instruments industry median EV-to-EBIT is 18.88. Eiken Chemical Co's value of 15.62 is 17.3% below this industry median. Based on the distribution chart, Eiken Chemical Co ranks #193 out of 481 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eiken Chemical Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eiken Chemical Co's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eiken Chemical Co ranks #193 out of 481 companies for EV-to-EBIT. This puts Eiken Chemical Co in the upper half of its industry. The industry median EV-to-EBIT is 18.88. Eiken Chemical Co's value of 15.62 is 17.3% below this benchmark. Historically, Eiken Chemical Co's own EV-to-EBIT has ranged from 4.62 to 26.00 over the past decade. While the company's 10-year median is 14.00 vs. the industry median of 18.88, Eiken Chemical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.88, based on 481 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eiken Chemical Co's current EV-to-EBIT of 15.62 is 17.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Eiken Chemical Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiken Chemical Co's current EV-to-EBIT is 15.62, which is 12% above median its own 10-year median of 14.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiken Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Eiken Chemical Co (TSE:4549) is currently considered Fairly Valued. The stock's GF Value™ is 円2,494.45, compared to a current price of 円2,350.00 — trading 5.8% below its estimated fair value. The current EV-to-EBIT is 15.62, which is 12% above median its 10-year median of 14.00 and 17.3% below the Medical Devices & Instruments industry median of 18.88. Eiken Chemical Co's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Eiken Chemical Co (TSE:4549), the current EV-to-EBIT is 15.62 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eiken Chemical Co (TSE:4549) Overvalued in 2026?
Based on GuruFocus' analysis, Eiken Chemical Co stock appears to be undervalued.
The current stock price of 円2,350.00 is trading 5.8% below its estimated GF Value™ of 円2,494.45.
GuruFocus considers Eiken Chemical Co to be Fairly Valued.
Key valuation signals for TSE:4549:
EV-to-EBIT: 15.62 (12% above median its 10-year median of 14.00)
GF Value™: 円2,494.45 vs. price of 円2,350.00 (5.8% below fair value)
Industry Position: 17.3% below the Medical Devices & Instruments median (#193 of 481)
No single metric tells the full story. See the TSE:4549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.
79GF Score
Get the complete analysis for TSE:4549
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4549 has been successfully added to your 
